Umbilical cord blood mononuclear cell(Guangzhou Xidi Biotech)

脐血单个核细胞（广州熙帝生物）

Report date: 2025/07/25 13:50:20

Base Information

Drug NameUmbilical cord blood mononuclear cell(Guangzhou Xidi Biotech)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Leukocyte cell therapy > Monocyte cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesGuangzhou Xidi Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGuangzhou Xidi Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A